Navigation Links
Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
Date:8/30/2007

Live audio webcast Thursday, September 6, 2007

SAN DIEGO, Aug. 30 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Neurocrine Biosciences will present at the BioCentury Newsmakers in the Biotech Industry Conference. The live presentation takes place Thursday, September 6, 2007 at 2:30 p.m. Eastern Time (ET) /11:30 a.m. Pacific Time (PT). The presentation will be simultaneously webcast and may be accessed on the Company's website at http://www.neurocrine.com

If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be archived on the website for two weeks.

About Neurocrine

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical Company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, endometriosis, pain, irritable bowel syndrome, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Newswire-FirstCall/--IES(Nasdaq: IESC ),aleadingna...andservicesforthecommercial,industrialandresidenti...rouphasbeenawardedacontractfromManhattanTorconJVto...ab(BSL-4)replacementfacilityattheU.S.ArmyMedicalRe...tDetrickinFrederick,Md. ,, ThenewUSAMRIIDreplac...
(Date:11/24/2009)... The New York investment bank KTA Capital,s client...n AU$6.7 mil convertible note private placement wi...ement was arranged by KTA Capital as Neuren,s excl... New York (PRWEB) November 23, 2009 -- ...al, LLC ("KTA Capital") has announced th...
(Date:11/24/2009)...M,Ontario,Nov.24/PRNewswire-FirstCall/--DowAgroSci...ylandSeeds,adivisionofThompsonsLimitedofBlenheim,O...wAgroSciences,currentseedsbusinessasthecompanyanti...ndDowAgroSciencesHerbicideTolerantTraitTechnologyi...arfuture. ,, "Thisacquisitionbringstogethertwos...
(Date:11/24/2009)...RNewswire-FirstCall/--Sigma-AldrichCorporation(Nas...eonTuesday,December1stat1:45PMGMTinLondon,7:45AMUS...stovertheInternetavailableat http://inve s tor....st"icontoaccessthisfile. ,, AboutSigma-Aldric...ologycompany.Itschemicalandbiochemicalproductsandk...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...VICL ) today announced that results from nonhuman ...accine for measles, published in the,August issue ...mising,approach to the development of a measles va...Vical recently reported breakthrough preliminary P...ic influenza DNA vaccines,formulated with the same...
...: ARPN) today announced that the European Medicine...ing Authorisation Application (MAA) for,intravenou...ous iclaprim in,the European Union for the treatme...(cSSTI). Iclaprim is a hospital antibiotic drug ca...y against MRSA and an extended range,of important ...
... 27th annual Inc. 500 ranking of the fastest-growi...mation Technology (IT) services provider,MicroTech...h of 1078.5%., The 2008 Inc. 500 list measures re...ompanies had to be U.S.-based, privately held, ind...ompanies - and have had at least,$200,000 in net s...
Other Biology Technology:Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants 2Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants 3Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants 4Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants 5Arpida's iclaprim MAA Accepted for Review by EMEA 2Arpida's iclaprim MAA Accepted for Review by EMEA 3MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2
(Date:11/24/2009)... in Spanish . , The presence of increased b...ry substances in the blood, hinders the loss and m...project of the University of Navarra conducted by ...l of Pharmacy. , The project, entitled "A nutrig...ontrol of body weight and inflammation," examines ...
(Date:11/23/2009)...09 - The time of day matters to forest trees deali... by a research team led by Professor Malcolm Campb...cipal for research and colleagues in the departmen...mpus. , Capitalizing on their previous work to...h team examined how poplar trees use their 45,000 ...
(Date:11/23/2009)...tudy provides "incontrovertible evidence" that the...Sumatra about 73,000 years ago deforested much of ..., researchers report. , The volcano ejected an e...sphere, leaving a crater (now the world,s largest ...kilometers wide. Ash from the event has been found...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2In the turf war against seaweed coral reefs more resilient than expected 8671 1In the turf war against seaweed coral reefs more resilient than expected 8671 2Vaccine shows therapeutic promise against advanced melanoma 47471 1Vaccine shows therapeutic promise against advanced melanoma 47471 2Vaccine shows therapeutic promise against advanced melanoma 47471 3Hispanic children in US at greater risk for obesity than other ethnic racial groups 47469 1Hispanic children in US at greater risk for obesity than other ethnic racial groups 47469 2
...limate change will have major effects on coral ree...e management. , A scientific team from the ARC Cen...at James Cook University has produced the world,s ... a reef is likely to suffer when confronted with m...ernational scientific journal Nature, Dr Joshua Ma...
...he healing wisdom of Pacific Island cultures by te...7th century Dutch herbal text for its anti-bacteri...om the Atun tree effectively control bacteria that...g Eberhard Rumpf, circa 1650. He documented his tr...bal. , The Mayo Clinic-led team,s report appears i...
...g the Brazilian rainforest is supplied by a valley...esearch team headed by Dr. Ilan Koren of the Insti...Department. In a study published recently in Envir...lained how the Bodélé valley,s unique features mig...provider. , It has been known for more than a deca...
Other Biology News:Stormy days ahead for coral reefs 2Stormy days ahead for coral reefs 3Mayo Clinic collaboration mining of ancient herbal text leads to potential new anti-bacterial drug 2Dust to gust 2
Goat Anti-IEX-1 S / L Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Rat WAVE 1 Monoclonal Antibody, Unconjugated, Clone 1.T.4 from Abcam
Mouse Oligodendrocyte Differentiation Kit from R&D Systems
Goat Anti-VAP-1 (S-13) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: